Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 631 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

NCT04522323

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site St Louis, Missouri, United States
  • Research Site New York, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03141177

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Local Institution - 0077 Daphne, Alabama, United States
  • Local Institution - 0044 Goodyear, Arizona, United States
  • Local Institution - 0132 Tucson, Arizona, United States
  • Local Institution - 0133 Bakersfield, California, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors

NCT05219318

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • CH de la Cote Basque - Service d'Oncologie Bayonne, France
  • CHU de Bordeaux - Service d'Oncologie Bordeaux, France
  • Centre François Baclesse - Service d'Oncologie Caen, France
  • Centre Jean Perrin - Service d'Oncologie Clermont-Ferrand, France
View all 26 locations
View Trial Details
Active, Not Recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations
  • City of Hope Duarte, California, United States
  • Northwell Health Manhasset, New York, United States
  • OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details

Related conditions